NovoCure Ltd’s recently made public that its Chief Operating Officer Paravasthu Mukund unloaded Company’s shares for reported $57906.0 on Jan 11 ’25. In the deal valued at $26.81 per share,2,160 shares were sold. As a result of this transaction, Paravasthu Mukund now holds 31,437 shares worth roughly $0.7 million.
Then, MUKUND PARAVASTHU bought 2,160 shares, generating $57,788 in total proceeds.
Before that, WILHELMUS C. GROENHUYSEN bought 266,085 shares. NovoCure Ltd shares valued at $7,929,333 were divested by the Officer at a price of $29.80 per share.
Evercore ISI upgraded its NovoCure Ltd [NVCR] rating to an Outperform from a an In-line in a research note published on December 02, 2024; the price target was increased to $30 from $18. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in mid October from “a Neutral” to “a Buy”. H.C. Wainwright revised its rating on August 28, 2023. It rated NVCR as “a Neutral” which previously was an “a Buy”.
Price Performance Review of NVCR
On Friday, NovoCure Ltd [NASDAQ:NVCR] saw its stock fall -2.97% to $22.25. Over the last five days, the stock has lost -9.26%. NovoCure Ltd shares have fallen nearly -25.34% since the year began. Nevertheless, the stocks have risen 49.63% over the past one year. While a 52-week high of $34.13 was reached on 01/02/25, a 52-week low of $11.70 was recorded on 02/07/25. SMA at 50 days reached $27.44, while 200 days put it at $20.32.
Levels Of Support And Resistance For NVCR Stock
The 24-hour chart illustrates a support level at 21.79, which if violated will result in even more drops to 21.34. On the upside, there is a resistance level at 22.94. A further resistance level may holdings at 23.64. The Relative Strength Index (RSI) on the 14-day chart is 28.09, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.91, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.96%. Stochastics %K at 10.10% indicates the stock is a buying.
How much short interest is there in NovoCure Ltd?
A steep rise in short interest was recorded in NovoCure Ltd stocks on 2025-01-15, dropping by -0.32 million shares to a total of 4.87 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 5.19 million shares. There was a decline of -6.54%, which implies that there is a negative sentiment for the stock.
